Publisher： Bentham Science Publishers
E-ISSN： 1875-6360|7|4|313-321
ISSN： 1573-3971
Source： Current Rheumatology Reviews, Vol.7, Iss.4, 2011-11, pp. : 313-321
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The antiphospholipid syndrome is characterized by the presence of arterial or venous thrombosis or recurrent miscarriages in a patient with positive laboratory tests for antiphospholipid antibodies (anticardiolipin antibodies and/or lupus anticoagulant and/or anti-beta2-glycoprotein I). Despite the strong association between antiphospholipid antibodies and thrombosis and obstetric morbidity, their pathogenic role in the development of these clinical features has not been fully elucidated. With respect to the treatment, at present there is consensus in treating patients with thrombosis with longterm oral anticoagulation. The approach for women with obstetric manifestations is based on the use of aspirin and heparin. However, the knowledge of new pathogenic mechanisms might identify novel therapeutic targets and therefore may improve the management of these patients.
Related content
By Castellino G. Khamashta M.A. Hughes G.R.V.
European Journal of Internal Medicine, Vol. 10, Iss. 4, 1999-12 ,pp. :
Access to resources
Recommend
Laboratory diagnosis of the antiphospholipid syndrome
By Wisloff F. Jacobsen E.M. Liestol S.
Thrombosis Research, Vol. 108, Iss. 5, 2002-12 ,pp. :
Antiphospholipid syndrome: treatment controversies
By Ruiz-Irastorza Guillermo Khamashta Munther A
Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. :